An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype.

Source:http://linkedlifedata.com/resource/pubmed/id/9715512

Download in:

View as

General Info

PMID
9715512